Type 1 diabetes with immune checkpoint inhibitors: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data
- Resource Type
- Article
- Source
- In
International Immunopharmacology September 2022 110 - Subject
- Language
- ISSN
- 1567-5769